Substance
ELVITEGRAVIR
Global reference: every product and company linked to this substance.
- cas: 697761-98-1
- ncit: C76493
- pubchem_cid: 5277135
- rxnorm: 1306286
- unii: 4GDQ854U53
elvitegravir [INN] · ELVITEGRAVIR [JAN] · ELVITEGRAVIR [USAN] · Elvitegravir [WHO-DD] · GS-9137 · JTK-303 · STRIBILD COMPONENT ELVITEGRAVIR · VITEKTA COMPONENT ELVITEGRAVIR
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| GILEAD SCIENCES INC. COMMON STOCK | GENVOYA | Q2 2026 | $289.0M* |
| GILEAD SCIENCES INC. COMMON STOCK | STRIBILD | Q4 2023 | $22.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- GENVOYA · GILEAD SCIENCES INC. COMMON STOCK
- STRIBILD · GILEAD SCIENCES INC. COMMON STOCK
- VITEKTA · GILEAD SCIENCES INC. COMMON STOCK